Infographic 1. Dermatologic manifestations of COVID-19-positive patients published thus far. Supplemental Material available via Mendeley at

No abstract

No abstract

No abstract

No abstract

The proportion of trials on novel therapies, including novel oral and biologic agents, has increased. The quality of trials has improved in the aspects of increased active treatment comparisons, including between biologics and conventional agents, and increased study size. Further insight into the influence of pharmaceutical companies can be studied by extending analysis to extension studies and subanalyses.

No abstract

No abstract